Baxter and Mayo Clinic partner to launch a renal care centre of excellence
Non-profit health organisation, the Mayo Clinic has announced its recent partnership with global innovator Baxter International to launch a new renal care centre of excellence at its campus in Jacksonville, Florida. The centre will serve patients across the continuum of renal care — from chronic kidney disease (CKD) management through transplant — and drive better patient outcomes.
The Mayo Clinic’s recognised excellence in care will be integrated with Baxter Renal Care Services' proven clinical service model and CKD management programme. The collaboration will also allow for the trial of potentially new, codeveloped products and services.
“The collaboration between Mayo Clinic and Baxter combines the best of our clinical, research and innovation expertise and is rooted in the shared goal to improve the way we care for patients with serious and complex illnesses,” says Gianrico Farrugia, M.D., CEO of Mayo Clinic in Florida and president-elect of Mayo Clinic.
See also
- Baylor Scott & White Health and Memorial Hermann Health System are set to merge
- Pfizer’s announces new CEO
- UnitedHealth acquires pharmaceutical company Genoa Healthcare for $2.5bn
Baxter Renal Care Services cares for more than 25,000 patients through its clinics across Asia, Europe and Latin America. Baxter Renal Care Services has historically worked closely with local experts to establish clinics where there is a need for centres of excellence that provide comprehensive care to help patients sequence through their therapy journey.
“We firmly believe there is a path to better care for kidney patients, which starts by managing the disease before dialysis is required and through simpler, more effective innovations,” adds Laura Angelini, general manager, Baxter’s Renal Care business. “Our collaboration with Mayo Clinic will allow us to go even further in helping to establish transformative care.”
It is the first collaboration initiative from the Baxter and Mayo Clinic five-year agreement, allowing the two healthcare leaders to bring together their respective clinical and development expertise.